Canonical Question
ANS Pharm – ANS drugs
Master answer
Organophosphate posisoning
SOURCE – insecticides, exposure to nerve agents (most commonly seen in farming settings)
PATHOPHYSIOLOGY
- Organophosphates form a covalent bond with acetylcholinesterase, inhibiting the metabolism of acetylcholine.
- This results in high levels of Ach at the neuromuscular junction (both nicotinic and muscarinic receptors), causing a cholinergic crisis
SYMPTOMS
- SLUDGE (salivation, urination, defaecation, gastrointestinal motility, emesis)
- CNS – confusion, anxiety, tremors, seizures
- CVS – bradycardia, hypotension
- RESP – respiratory impairment due to muscle weakness, difficulty clearing secretions
MANAGEMENT
- Remove the patient from the source of poisoning
- PPE for staff – mask, goggles, neoprene gloves and gowns rather than latex as hydrocarbons can penetrate latex
- ABC’s and resuscitation as required
- Decontamination –
- activated charcoal / gastric lavage / whole bowel irrigation unlikely to be effective due to rapid absorption of organophosphates.
- Clothes should be removed and discarded and the patient bathed with soap and water to remove organophosphates from skin.
- Irrigate the eyes if ocular exposure has occurred.
- Symptom control
- Anti muscarinic agents –
- atropine in large doses will reduce the antimuscarinic effects by competitively antagonizing Ach at the receptor.
- ETG suggests 1.2-3mg boluses, aiming SBP>80mmHg, HR >80bpm and absence of wheeze, doubling the dose every 5 mins until atropinisation is achieved, followed by an infusion.
- Glycopyrrolate can be used to reduce secretions post initial atropinisation, however does not cross the BBB so will have no effect on the central cholinergic effects
- There is no antinicotinic agent so supportive care only for muscle weakness.
- Benzodiazepines for seizure control
- Anti muscarinic agents –
- Definitive treatment
- Cholinesterase regenerator (an oxime such as pralidoxime) may reactive AchE and prevent the organophosphate-acetylocholinesterase complex ageing and becoming an irreversible bond if given within 48 hrs
Exam appearances
| Exam | Exact wording | Relationship | Success |
|---|---|---|---|
| 2009A Q20 | Describe the pharmacological basis of the management of organophosphate poisoning. | historical_member | — |